by in Accident Insurance, BTA, Resource Center, Specialty Accident.

Business travel is back and expected to exceed pre-pandemic numbers by 2026. In recent years, however, the travel environment has changed dramatically. Business travelers face new threats of all types – cyberattacks disrupting flights, severe weather events, geopolitical conflict, civil unrest, and increased motor vehicle accidents. Download the 2024 Business Travel Risk Trends and Insights Read More

by in Resource Center, Special Risk.

There are many misconceptions about insurance coverage while employees are on the road. In this article, learn the facts about business travel coverage. Myth: “Business Travel Accident (BTA) insurance only covers international work trips.” Fact: It can cover both international and domestic travel, including client meetings across the street, trips to the office supply store, and Read More

by in Gene Therapy, Resource Center.

Cell and gene therapy treatments are a groundbreaking frontier in medical treatment, promising not just to alleviate symptoms, but potentially cure life-threatening diseases. These therapies work by altering the genetic material inside a patient’s cells, offering solutions to genetic disorders and diseases previously deemed untreatable. How Cell and Gene Therapy Works At its core, cell Read More

by in Group Captive, Resource Center, Risk Management, Stop Loss.

Navigating rising health care costs can be a significant challenge for companies, especially small and midsize employers. At Berkley Accident and Health, we are committed to helping companies offer affordable, quality health benefits through Group Captive programs. Group Captive programs offer a way for small and midsize firms to self-fund, just like large corporations do.  Read More

by in Group Captive, Resource Center, Risk Management, Stop Loss.

GLP-1, or glucagon-like peptide-1 drugs, are a synthetic version of the body’s naturally occurring hormone that reduces appetite and slows down the rate at which food leaves the stomach. Originally developed to treat diabetes, GLP-1s’ popularity has skyrocketed because of their use for weight loss. In 2023, GLP-1s alone accounted for nearly 7% of the Read More

by in Resource Center, Risk Management, Special Risk.

In this article, we will look at ISO 31030 and discuss how companies can use this benchmark to review their own risk management strategies for domestic and international travel. Business travel has changed considerably since the pandemic. Whether it’s heightened awareness about illness or increased threats from civil unrest and natural disasters, companies should reassess Read More

| a Berkley Company